Paclitaxel targets FOXM1 to regulate KIF20A in mitotic catastrophe and breast cancer paclitaxel resistance

P. Khongkow, A. R. Gomes, C. Gong, E. P.S. Man, J. W.H. Tsang, F. Zhao, L. J. Monteiro, R. C. Coombes, R. H. Medema, U. S. Khoo, E. W.F. Lam*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

168 Scopus citations


FOXM1 has been implicated in taxane resistance, but the molecular mechanism involved remains elusive. In here, we show that FOXM1 depletion can sensitize breast cancer cells and mouse embryonic fibroblasts into entering paclitaxel-induced senescence, with the loss of clonogenic ability, and the induction of senescence-associated β-galactosidase activity and flat cell morphology. We also demonstrate that FOXM1 regulates the expression of the microtubulin-associated kinesin KIF20A at the transcriptional level directly through a Forkhead response element (FHRE) in its promoter. Similar to FOXM1, KIF20A expression is downregulated by paclitaxel in the sensitive MCF-7 breast cancer cells and deregulated in the paclitaxel-resistant MCF-7TaxR cells. KIF20A depletion also renders MCF-7 and MCF-7TaxR cells more sensitive to paclitaxel-induced cellular senescence. Crucially, resembling paclitaxel treatment, silencing of FOXM1 and KIF20A similarly promotes abnormal mitotic spindle morphology and chromosome alignment, which have been shown to induce mitotic catastrophe-dependent senescence. The physiological relevance of the regulation of KIF20A by FOXM1 is further highlighted by the strong and significant correlations between FOXM1 and KIF20A expression in breast cancer patient samples. Statistical analysis reveals that both FOXM1 and KIF20A protein and mRNA expression significantly associates with poor survival, consistent with a role of FOXM1 and KIF20A in paclitaxel action and resistance. Collectively, our findings suggest that paclitaxel targets the FOXM1-KIF20A axis to drive abnormal mitotic spindle formation and mitotic catastrophe and that deregulated FOXM1 and KIF20A expression may confer paclitaxel resistance. These findings provide insights into the underlying mechanisms of paclitaxel resistance and have implications for the development of predictive biomarkers and novel chemotherapeutic strategies for paclitaxel resistance.

Original languageEnglish
Pages (from-to)990-1002
Number of pages13
Issue number8
StatePublished - 25 Feb 2016

Bibliographical note

Funding Information:
EW-F Lam, AR Gomes and RC Coombes were supported by grants from Cancer Research UK; EW-F Lam by grants from Breast Cancer Campaign; P Khongkow, from the Royal Thai Government Scholarships. US Khoo received funding from Committee on Research and Conference Grants from the University of Hong Kong (CRCG) (201007176118). We also thank Muhammad Zaini, Marios Poullas and Laura Bella for help with this work.

Publisher Copyright:
© 2016 Macmillan Publishers Limited. All rights reserved.


Dive into the research topics of 'Paclitaxel targets FOXM1 to regulate KIF20A in mitotic catastrophe and breast cancer paclitaxel resistance'. Together they form a unique fingerprint.

Cite this